Previous Publications
3rd International Workshop
Third International Workshop on the Biology, Prevention and Treatment of Relapse After Stem Cell Transplantation
Prevention and Treatment of Relapse After Stem Cell Transplantation and Immunotherapy
Prevention and Treatment of Relapse After Stem Cell Transplantation in Lymphoid Malignancies
Methods to Prevent and Treat Relapse After Hematopoietic Stem Cell Transplantation with Tyrosine Kinase Inhibitors, Immunomodulating Drugs, Deacetylase Inhibitors, and Hypomethylating Agents
Methods and Role of Minimal Residual Disease After Stem Cell Transplantation
Prevention of Relapse After Allogeneic Hematopoietic Cell Transplantation by Donor and Cell Source Selection
Prevention and Treatment of Relapse After Stem Cell Transplantation by Cellular Therapies
Current Status and Future Clinical Directions in the Prevention and Treatment of Relapse Following Hematopoietic Transplantation for Acute Myeloid
and Lymphoblastic Leukemia
Selected Biological Issues Affecting Relapse After Stem Cell Transplantation: Role of T-cell Impairment, NK Cells and Intrinsic Tumor Resistance
2nd International Workshop
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After
Hematopoietic Stem Cell Transplantation: Introduction
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: Part I. Biology of Relapse After Transplantation
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After
Hematopoietic Stem Cell Transplantation: Part II. Autologous Transplantation - Novel Agents and Immunomodulatory Strategies
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
1st International Workshop
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Epidemiology and Natural History of Relapse Following Allogeneic Cell Transplantation
Third International Workshop on the Biology, Prevention and Treatment of Relapse After Stem Cell Transplantation
Prevention and Treatment of Relapse After Stem Cell Transplantation and Immunotherapy
Prevention and Treatment of Relapse After Stem Cell Transplantation in Lymphoid Malignancies
Methods to Prevent and Treat Relapse After Hematopoietic Stem Cell Transplantation with Tyrosine Kinase Inhibitors, Immunomodulating Drugs, Deacetylase Inhibitors, and Hypomethylating Agents
Methods and Role of Minimal Residual Disease After Stem Cell Transplantation
Prevention of Relapse After Allogeneic Hematopoietic Cell Transplantation by Donor and Cell Source Selection
Prevention and Treatment of Relapse After Stem Cell Transplantation by Cellular Therapies
Current Status and Future Clinical Directions in the Prevention and Treatment of Relapse Following Hematopoietic Transplantation for Acute Myeloid
and Lymphoblastic Leukemia
Selected Biological Issues Affecting Relapse After Stem Cell Transplantation: Role of T-cell Impairment, NK Cells and Intrinsic Tumor Resistance
2nd International Workshop
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After
Hematopoietic Stem Cell Transplantation: Introduction
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: Part I. Biology of Relapse After Transplantation
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After
Hematopoietic Stem Cell Transplantation: Part II. Autologous Transplantation - Novel Agents and Immunomodulatory Strategies
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
1st International Workshop
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Epidemiology and Natural History of Relapse Following Allogeneic Cell Transplantation
